Vaginal Mesh Settlements Top $2.6B in Payments by Endo to Resolve All Lawsuits
Endo Pharmaceuticals plans to pay nearly $800 million to resolve thousands of remaining vaginal mesh lawsuits.
Endo Pharmaceuticals plans to pay nearly $800 million to resolve thousands of remaining vaginal mesh lawsuits.
Endo has ended all vaginal mesh production by shutting down its Astora Woman's Health division, in order to prevent more vaginal mesh litigation.
The FDA has announce new rules that reclassify transvaginal mesh products as high-risk medical devices and will require them to go through a more stringent approval process showing safety and…
Another group status conference has been ordered for all vaginal mesh lawsuits in an effort to reach a settlement that would avoid tens of thousands of trials.
Virtually all AMS vaginal mesh lawsuits have now been settled, with combined payments expected to exceed $1.6 billion.
Nearly 60,000 lawsuits involving vaginal mesh and bladder sling products are currently pending in federal MDLs.
AMS's parent company, Endo, will pay $830 million to settle most of the vaginal mesh lawsuits against it, the company announced this week.
The FDA has proposed reclassifying transvaginal mesh products as high-risk medical devices.
Endo subsidiary AMS has received an FDA warning letter about processes at its Minnesota manufacturing plant, which makes pelvic mesh products that have been the subject of thousands of product…
A postponed Bard Avaulta vaginal mesh trial has been rescheduled for May as a judge prepares the next wave of cases for trial.